Pan Cancer T

Biotech · Rotterdam, NL

Erasmus MC spin-out developing next-generation TCR-T therapies for solid tumors.

In the network

Shares the most investors with (number = shared investors):

Create a free EquityFlow account to see Pan Cancer T's 2 funding rounds, 5 investors, 12 similar companies.